Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioAge Labs, Inc. - Common Stock
(NQ:
BIOA
)
9.040
-15.810 (-63.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about BioAge Labs, Inc. - Common Stock
< Previous
1
2
Next >
Top movers in Friday's session
↗
Today 15:00 EDT
Via
Chartmill
Top stock movements in today's session.
↗
Today 12:30 EDT
Via
Chartmill
Gapping stocks in Friday's session
↗
Today 10:30 EDT
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
Today 8:30 EDT
Via
Chartmill
BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease
↗
June 06, 2026
BioAge Labs (NASDAQ:BIOA) executives used a fireside chat at the Jefferies 2026 Global Healthcare Conference to outline the company’s plans for BGE-102, its lead NLRP3 inhibitor, with near-term...
Via
MarketBeat
A Healthcare Fund Just Made Bitgo Its Biggest Bet
↗
May 19, 2026
Bitgo Holdings provides digital asset infrastructure and custody services for institutional clients, supporting secure management at scale.
Via
The Motley Fool
Topics
Regulatory Compliance
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials
↗
May 08, 2026
BioAge Labs (NASDAQ:BIOA) used its R&D Day event to provide an update on its lead program, BGE-102, an oral, brain-penetrant inhibitor of the NLRP3 inflammasome that the company is developing across...
Via
MarketBeat
Tuesday's after hours session: top gainers and losers
↗
January 06, 2026
Via
Chartmill
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole
↗
December 13, 2025
Don't be too quick to jump on this biotech bandwagon.
Via
The Motley Fool
BioAge Labs Inc (NASDAQ:BIOA) Reports Q3 2025 Earnings with Significant Revenue Beat
↗
November 06, 2025
BioAge Labs reported a mixed Q3 2025, beating revenue estimates by 94% with a narrower EPS loss. The clinical-stage biotech advanced its lead drug, BGE-102, with cash runway through 2029.
Via
Chartmill
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
↗
November 05, 2025
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
Via
The Motley Fool
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
↗
October 29, 2025
This stock has caught fire after some recent events, but how long will that last?
Via
The Motley Fool
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
↗
October 26, 2025
The clinical-stage biotech is working on a new type of weight management drug.
Via
The Motley Fool
Here are the top movers in Thursday's session.
↗
October 23, 2025
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 23, 2025
Via
Benzinga
Which stocks are moving on Thursday?
↗
October 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
These stocks are gapping in today's session
↗
October 23, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
October 23, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 23, 2025
Via
Benzinga
This Badger Meter Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
↗
October 22, 2025
Via
Benzinga
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M
↗
August 06, 2025
Via
The Motley Fool
Topics
Intellectual Property
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Crude Oil Gains 2%; BioAge Labs Shares Plunge
↗
December 09, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
↗
December 09, 2024
Via
Benzinga
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
↗
December 09, 2024
Via
Benzinga
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
↗
December 09, 2024
BioAge Labs halts STRIDES Phase 2 trial of azelaprag after liver enzyme elevations, plans further analysis with updates expected in Q1 2025.
Via
Benzinga
Topics
Initial Public Offering
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
↗
December 09, 2024
Via
Benzinga
Self-Driving Startup Pony.ai Files For U.S. IPO
↗
October 20, 2024
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group...
Via
Talk Markets
Topics
Initial Public Offering
Prediction: These 2 Stocks Could Soar in 2025
↗
October 17, 2024
The key word here is "could."
Via
The Motley Fool
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
